News
A genetic test will improve the diagnosis of a rare cancer predisposition syndrome in children
Researchers have developed a genetic test that will improve the diagnosis of CMMRD, a rare cancer predisposition syndrome in children. The analysis of only a selection of genetic segments allows this test to be fast and accessible to healthcare professionals.
Researchers discover biomarkers that predict response to immunotherapy in skin carcinoma
IDIBELL researchers have discovered a mechanism by which tumor cells respond differentially to various immunotherapies and have identified biomarkers that predict the response to these drugs. Published in Nature Communications, this finding would allow personalizing the treatment of skin carcinoma and thus increase the patients quality of life.
New Queer Group at IDIBELL to promote diversity in biomedical research
At IDIBELL, we are proud to announce that this month the negotiating table for the first IDIBELL LGBTIAQ+ Plan has been constituted. Additionally, IDIBELL is inviting members to join the new Queer group, a meeting space for the LGBTIAQ+ community.
Fecal microbiota transplantation emerges as a safe and effective alternative to antibiotics for C. difficile infection
150 recurrent cases of C. difficile in Catalonia could be treated with Fecal Microbiota Transplantation each year
Telemedicine improves follow-up of patients with advanced hematological treatments
Recent research by the Hematology and Digital Health groups of IDIBELL and ICO shows that the use of smart watches and mobile apps improves the follow-up of patients who have received a bone marrow transplant or CAR-T therapy.
The role of the epidermal growth factor receptor in chronic liver damage has been proven
Researchers from IDIBELL, CIBER and the Complutense University, led by Dr. Isabel Fabregat, link EGFR signaling to fibrotic and inflammatory processes in the liver. The findings, obtained with a mouse model, could be transferred to patients suffering from a fibrotic process.
More than a hundred experts meet in Barcelona to discuss the latest advances in the treatment of onco-haematological diseases
M. Carolina Florian and Alessandra Giorgetti, group leaders of the Regenerative Medicine Program at IDIBELL, are part of the organizing committee. The congress featured more than ten national and international speakers, and 135 participants.
The IDIBELL and Institut Bellvitge Tandem consolidates its scientific education activities
The II Biomedicine Congress of the URIB, this year on research ethics and vaccines, has concluded the 2023/24 Tandem academic course. The 7th issue of Life&Science magazine is published, including an interview with Dr. Anna Veiga and a report on the ecological footprint of research.
Exposure to cold and heat in the first years of life can affect the development of the brain’s white matter
The study underscores the vulnerability of fetuses and children to cold and heat, and the need to protect the most vulnerable communities from the effects of climate change.